Toboroz
A Study on the Efficacy of a Vaccine Against Influenza in Adults ≥65 Years of Age
NCT07805707· 3. fázis· GlaxoSmithKline· Forrás
Contact: Christina Kennelly (principal investigator)
Toboroz
A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)
NCT07519395· 2. fázis· GlaxoSmithKline· Forrás
Contact: Christopher Dean Ferris (principal investigator)
Toboroz
A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)
NCT07202546· 2. fázis· ViiV Healthcare· Forrás
Contact: Marc Johnson (principal investigator)
Toboroz
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
NCT06679101· 3. fázis· GlaxoSmithKline· Forrás
Contact: Raymond Thertulien (principal investigator)
Toboroz
Study to Assess Real-world Effectiveness of Belimumab for Treatment of Adults With LN
NCT06527872· GlaxoSmithKline· Forrás
Contact: Gordon Lam (principal investigator)
Fut, nem toboroz
A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE)
NCT06411249· 4. fázis· GlaxoSmithKline· Forrás
Fut, nem toboroz
Pragmatic Open - Label Randomized Clinical Trial of FF/UMEC/VI vs Non-ellipta Usual Care ICS-LABA for Adult Participants With Uncontrolled Asthma
NCT06372496· 4. fázis· GlaxoSmithKline· Forrás
Fut, nem toboroz
A Study on the Long-term Efficacy, Safety and Persistence of Immune Response of a Vaccine Against Herpes Zoster in Older Adults
NCT05371080· 3. fázis· GlaxoSmithKline· Forrás
Fut, nem toboroz
Efficacy and Safety of Depemokimab Compared With Mepolizumab in Adults With Relapsing or Refractory Eosinophilic Granulomatosis With Polyangiitis (EGPA)
NCT05263934· 3. fázis· GlaxoSmithKline· Forrás
Fut, nem toboroz
First-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid Tumors
NCT05277051· 1. fázis· GlaxoSmithKline· Forrás
Fut, nem toboroz
Safety, Tolerability, and Immunogenicity of MenABCWY Administered on Different Dosing Schedules in Healthy Adolescents
NCT05087056· 2. fázis· GlaxoSmithKline· Forrás
Toboroz
A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study
NCT04641247· 2. fázis· GlaxoSmithKline· Forrás
Contact: Antoinette Tan (principal investigator)
Fut, nem toboroz
Study of Belantamab Mafodotin Plus Standard of Care (SoC) in Newly Diagnosed Multiple Myeloma
NCT04091126· 1. fázis· GlaxoSmithKline· Forrás
Fut, nem toboroz
A Study to Evaluate Dostarlimab Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Participants With Recurrent or Primary Advanced Endometrial Cancer
NCT03981796· 3. fázis· Tesaro, Inc.· Forrás
Fut, nem toboroz
A Comparison of Platinum-based Therapy With TSR-042 and Niraparib Versus Standard of Care (SOC) Platinum-based Therapy as First-line Treatment of Stage III or IV Nonmucinous Epithelial Ovarian Cancer
NCT03602859· 3. fázis· Tesaro, Inc.· Forrás
Fut, nem toboroz
Efficacy, Safety and Tolerability Study of Long-acting Cabotegravir Plus Long-acting Rilpivirine (CAB LA + RPV LA) in Human-immunodeficiency Virus-1 (HIV-1) Infected Adults
NCT03299049· 3. fázis· ViiV Healthcare· Forrás
Fut, nem toboroz
Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine From Current Antiretroviral Regimen in Virologically Suppressed HIV-1-infected Adults
NCT02951052· 3. fázis· ViiV Healthcare· Forrás
Fut, nem toboroz
Study of TSR-042, an Anti-programmed Cell Death-1 Receptor (PD-1) Monoclonal Antibody, in Participants With Advanced Solid Tumors
NCT02715284· 1. fázis· Tesaro, Inc.· Forrás